On September 4th, North China Pharmaceutical (600812.SH) stated on the investor interaction platform that the company's vitamin series products include the vitamin B12 series and the vitamin C series. The company will arrange production and operation in a reasonable manner based on market demand and its own situation.
华北制药(600812.SH)：维生素系列产品包括维生素B12系列和维生素C系列
North China Pharmaceutical (600812.SH): The vitamin series products include the vitamin B12 series and the vitamin C series.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.